Equities

Nihon Kohden Corp

Nihon Kohden Corp

Actions
Health CareMedical Equipment and Services
  • Price (JPY)4,612.00
  • Today's Change19.00 / 0.41%
  • Shares traded249.20k
  • 1 Year change+22.33%
  • Beta-0.0265
Data delayed at least 20 minutes, as of May 27 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

NIHON KOHDEN CORPORATION is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company mainly operates medical electronics related business. The Company offers electroencephalograph, electromyographic, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses.

  • Revenue in JPY (TTM)221.99bn
  • Net income in JPY17.03bn
  • Incorporated1951
  • Employees5.75k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Japan Lifeline Co., Ltd.51.38bn7.52bn85.91bn1.17k11.511.469.561.6798.5598.55675.02775.420.69371.443.88--10.158.6312.5710.8860.3057.2814.6312.281.96--0.071743.63-0.70732.459.06-0.54465.407.69
HOGY MEDICAL CO., LTD.39.10bn2.80bn99.26bn1.44k34.011.1110.562.54115.55115.551,611.173,547.480.38672.844.99--2.764.243.064.6733.4139.767.1411.584.07--0.061842.570.30531.30-35.03-14.247.944.56
Menicon Co Ltd116.19bn4.54bn103.00bn4.06k24.411.259.890.886455.0655.061,433.511,072.690.69933.059.13--2.734.533.525.6752.5152.973.915.721.3413.770.463926.445.447.51-38.484.8832.6112.30
PHC Holdings Corp353.90bn-12.89bn133.31bn9.40k--0.9548.850.3767-102.49-102.492,809.951,106.970.62873.754.95---2.28-0.0766-3.03-0.116444.6447.69-3.63-0.12680.91720.11580.672---0.710913.66-300.16--16.68--
Paramount Bed Holdings Co Ltd106.02bn10.62bn158.71bn3.95k14.061.0811.591.50182.83182.831,822.432,368.790.60185.164.19--6.035.597.066.5947.7646.9110.029.593.43--0.04236.497.085.7715.279.6416.645.39
Mani Inc26.37bn6.58bn197.29bn3.69k27.603.5222.787.4866.8266.82267.74523.800.49331.5212.007,156,310.0012.3111.4413.2112.3164.2263.2824.9626.117.32--0.00151.2519.954.0312.539.5624.1220.11
Nipro Corp586.79bn11.11bn202.32bn38.77k19.900.82722.850.344859.2959.293,281.241,426.550.54911.913.77--1.140.79231.741.2129.2029.992.071.450.8107--0.700260.647.636.59142.87-1.7510.97-2.24
NAKANISHI INC.64.24bn22.91bn216.36bn2.05k8.631.698.013.37268.25268.25751.841,372.280.51171.228.3231,350,210.0018.2512.7121.0214.0259.6661.4135.6726.601.98--0.112728.1222.6410.3183.1024.6511.2812.30
Ship Healthcare Holdings Inc630.99bn13.79bn236.53bn8.05k16.321.5718.700.3749142.55142.556,363.891,478.711.6421.164.87--3.573.637.146.8610.4010.522.182.291.29--0.289431.2510.267.2814.314.183.095.15
Fukuda Denshi Co Ltd140.32bn18.69bn238.94bn3.38k10.161.0811.531.70622.92622.924,672.475,863.200.67474.223.62--8.998.0710.8710.1753.0547.8313.3211.133.01--0.020417.174.211.588.1914.3111.0015.85
NIHON KOHDEN CORPORATION221.99bn17.03bn405.24bn5.75k22.682.1319.551.83202.55202.552,639.502,158.390.98671.903.36--7.578.669.6311.4050.1650.857.678.412.54--0.003622.777.454.42-0.49098.758.0511.75
ASAHI INTECC CO., LTD.101.06bn15.16bn579.94bn10.19k38.254.0023.415.7455.8255.82372.06533.450.59121.235.629,920,487.008.949.5710.2811.2064.3766.7815.1215.932.8384.060.054328.1315.8912.4420.715.479.128.31
Data as of May 27 2024. Currency figures normalised to Nihon Kohden Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

37.42%Per cent of shares held by top holders
HolderShares% Held
Sprucegrove Investment Management Ltd.as of 31 Mar 20239.29m10.53%
ValueAct Capital Management LPas of 18 Dec 20234.42m5.01%
Nomura Asset Management Co., Ltd.as of 30 Apr 20242.94m3.33%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 29 Dec 20232.77m3.14%
First Eagle Investment Management LLCas of 28 Mar 20242.71m3.07%
The Vanguard Group, Inc.as of 09 May 20242.53m2.87%
ARGA Investment Management LPas of 31 Jan 20242.26m2.56%
Norges Bank Investment Managementas of 31 Dec 20232.16m2.45%
Asset Value Investors Ltd.as of 31 Jan 20242.08m2.36%
Resona Asset Management Co., Ltd.as of 31 Mar 20231.85m2.09%
More ▼
Data from 11 Dec 2023 - 23 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.